Shop by goal
Popular compounds
Research resources
Recently viewed
Is Epitalon FDA Approved? The 2026 Regulatory Status, Explained
Short answer: no. Epitalon (also searched as Epithalon or Epithalin) is not an FDA-approved drug. It is supplied strictly as a research-use-only compound, not for human consumption. Epitalon is on the FDA’s July 24, 2026 compounding advisory committee agenda (evaluated use: insomnia) — a review of possible 503A Bulks List inclusion, which is not drug approval, and not an endorsement of any anti-ageing claim.
Epitalon attracts a lot of attention in longevity circles, and with it a lot of regulatory confusion. The question “is Epitalon FDA approved?” has a clear answer — no — but the longevity marketing around the compound makes it worth stating carefully.
What “FDA approved” actually means
FDA approval requires a New Drug Application supported by clinical trials, after which the FDA decides whether a drug is safe and effective for a specific indication. Epitalon has not been through that process; there is no approved application and no FDA-standard trial programme. See our FDA peptide approval pipeline guide for the peptides that have.
Is Epitalon FDA approved? The current status
No. Epitalon is a synthetic tetrapeptide developed in Russia and studied in longevity, cellular-ageing and sleep-related research — including discussion around telomerase and circadian biology. It is also commonly searched under the spellings Epithalon and Epithalin. Under any spelling, it has no FDA approval and is handled as a research compound: supplied to laboratories as a reagent, labelled research use only, not for human consumption.
Longevity marketing, meet reality. Epitalon is often promoted online with dramatic anti-ageing language. None of that reflects FDA approval, and no responsible source should claim Epitalon “reverses ageing” or is a cleared therapy. The research is interesting; the marketing frequently runs far ahead of it.
The July 2026 FDA review: still not approval
On July 24, 2026, the FDA’s Pharmacy Compounding Advisory Committee is scheduled to discuss Epitalon bulk drug substances (free base and acetate), with insomnia listed as the evaluated use, as part of a review for potential 503A Bulks List inclusion. Note that the evaluated use is insomnia — not the anti-ageing or longevity framing the compound is usually marketed under — and that the 503A list concerns pharmacy compounding, not drug approval. A recommendation there would not make Epitalon an FDA-approved medicine. The neuro-longevity compounds are covered together in our Semax, Epitalon and DSIP review.
Why Epitalon isn’t approved
Most of the Epitalon literature is pre-clinical or small-scale and largely Russian in origin, rather than the large, controlled, FDA-standard trials approval requires. Combined with the lack of a sponsor taking it through the US process, there is no approval pathway in progress. As always, that describes the evidence status, not a judgement on the underlying biology.
What this means if you research Epitalon
Because Epitalon is not approved, responsible suppliers position it for laboratory research use only, not for human consumption, and back it with batch-specific testing. Look for a Certificate of Analysis confirming identity and purity, and be especially sceptical of longevity sellers claiming Epitalon is “FDA approved” or an approved anti-ageing therapy — neither is accurate.
Frequently Asked Questions
Is Epitalon FDA approved? No. It is not an FDA-approved drug; it is supplied as research-use-only material, not for human consumption.
Is Epitalon the same as Epithalon? Yes — Epitalon, Epithalon and Epithalin refer to the same synthetic tetrapeptide. None is FDA approved.
Does the 2026 meeting approve Epitalon for anti-ageing? No. It is a compounding-list review (evaluated use: insomnia), not a drug approval and not an endorsement of any longevity claim.
Related Reading
Source: the FDA’s July 23–24, 2026 Pharmacy Compounding Advisory Committee meeting agenda. External links are provided for research reference only; New-U is not affiliated with these organisations and links carry no endorsement either way.
From the Lab - Peptides on LinkedIn & Facebook
Lab-Verified Research Compounds
New-U Research Compounds supplies sealed 10-vial packs, independently verified by Janoshik and Freedom Diagnostics for >99% purity, with a Certificate of Analysis. Research use only - not for human consumption.
At New-U, we believe better conversations start with better information. For laboratory research use only. Not for human consumption.
Research-grade · >99% HPLC purity · COA per lot
Buy Epitalon from New-U Research Compounds
Lab-verified by Janoshik Analytical (RP-HPLC + ESI-MS), sealed vials, discreet tracked worldwide shipping. For laboratory research use only — not for human consumption.
Premium research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical with a Certificate of Analysis on every lot. Shipped lab-direct, discreet and cold-chain, worldwide. For laboratory research use only.
Shop
Learn
Company
Support
Ways to Pay
Shop by Compound
Shop by Goal
Ships worldwide
Research use only (RUO). All products are sold strictly for laboratory and research purposes — not for human or veterinary consumption. Purchasers must be 21 or older.
All rights reserved. Copyright of New-U held with Hilxera Distribution Services LLC 2026.
Website & business operated by Hilxera Distribution Services LLC. Registered in Wyoming, ID: 2026-001928701.
© 2026 New-U Research Compounds · new-u.io · @new.u.io